Institutional Ownership
Inmune Bio Inc
CUSIP 45782T105COMINMBQ1 2026
13D / 13G Filings
20
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
17.7%
Max % of class reported
Institutional Holders
77
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
20 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Cvi Investments, Inc. | 13G/A | 4.9% | 1.40M | SEC |
| 2 | Aug 14, 2025 | Praetorian Pr LLC | 13G/A | 3.4% | 921.2K | SEC |
| 3 | Aug 14, 2025 | Highbridge Capital Management, LLC | 13G/A | 5.2% | 1.45M | SEC |
| 4 | Jul 2, 2025 | Cvi Investments, Inc. | 13G | 5.5% | 1.50M | SEC |
| 5 | Apr 10, 2025 | Praetorian Pr LLC | 13G/A | 7.2% | 1.66M | SEC |
| 6 | Jan 15, 2025 | Praetorian Pr LLC | 13G | 5.5% | 1.24M | SEC |
| 7 | Oct 25, 2024 | Highbridge Capital Management LLC | 13G | 6.6% | 1.45M | SEC |
| 8 | Oct 2, 2024 | Xencor Inc | 13G/A | 9.6% | 1.89M | SEC |
| 9 | Feb 15, 2023 | Xencor Inc | 13G | 10.5% | 1.89M | SEC |
| 10 | Apr 21, 2022 | Tesi Raymond Joseph | 13D/A | 11.6% | 2.16M | SEC |
10 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Inmune Bio Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 1.19M | $1.35M |
| 2 | Geode Capital Management, LLC | 495.0K | $559.5K |
| 3 | State Street Corp | 290.9K | $328.7K |
| 4 | Aqr Capital Management LLC | 270.3K | $305.5K |
| 5 | Ubs Group AG | 253.3K | $286.3K |
| 6 | Goldman Sachs Group Inc | 231.6K | $261.7K |
| 7 | Raymond James Financial Inc | 203.2K | $229.7K |
| 8 | Susquehanna International Group, LLP | 194.4K | $219.7K |
| 9 | Northern Trust Corp | 184.2K | $208.2K |
| 10 | Dauntless Investment Group, LLC | 183.5K | $207.3K |